Tron Group (TGRP) Stock Price, News & Analysis
Company Description
Tron Group (OTC Link: TGRP) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $5.5M.
TGRP has gained 0.0% over the past year. Shares last traded at $0.0300.
This page collects what Stock Titan holds for TGRP, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Tron Group (TGRP) stock last closed at $0.0300. Over the past 12 months, the stock has gained 0.0%. At a market capitalization of $5.5M, TGRP is classified as a micro-cap stock with approximately 184.0M shares outstanding.
Latest News
Tron Group has 6 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. Key topics include clinical trial, acquisition, partnership, crypto. View all TGRP news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Tron Group (TGRP) currently stands at 6.2 thousand shares, up 281.5% from the previous reporting period, representing 0.0% of the shares outstanding. Since September 2025, short interest has increased by 439.4%.
Days to Cover History
Days to cover for Tron Group (TGRP) currently stands at 1.1 days, down 99.9% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
TGRP Company Profile & Sector Positioning
Tron Group (TGRP) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing TGRP often look at related companies in the same sector, including ASEP MED HLDGS INC (SEPSF), Nymox Pharm (NYMXF), Orgenesis Inc (ORGS), Kane Biotech Inc (KNBIF), and Biophytis Sa (BPTSY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TGRP's relative position within its industry.